HIGH END UPDATES
Recieve Product Updates, Store Deals and more!
Popular Brands
Plaid Jacket – SUbx – Sweet water Farms – Mako farm
Weekly Deals
Try Something New Every Day!
Find US
Tap the map for directions!
UPDATES + EVENTS + NEW DROPS
Check back for frequent updates!
Federal Cannabis Rescheduling Could Change the Future of Marijuana Dispensaries in America
The Cannabis industry in the United States is going through one of the biggest changes it has seen since legalization first began spreading state by state. In 2026, the federal government officially moved forward with efforts to reclassify Marijuana under federal law, creating major conversations across the Cannabis industry and inside nearly every Dispensary in the country.
For years, Marijuana has been classified as a Schedule I substance under the Controlled Substances Act. This placed Cannabis in the same category as drugs considered to have no accepted medical use at the federal level. Even as states legalized medical and recreational Marijuana, federal law remained unchanged. That conflict created major challenges for Cannabis businesses, growers, processors, and Dispensary owners across the United States.
In April 2026, the U.S. Department of Justice announced a major shift involving federally approved and state-licensed medical Cannabis products. Certain Marijuana products were moved into Schedule III classification, marking one of the most important federal Cannabis policy updates in decades. While this does not fully legalize Marijuana federally, it is still viewed as a massive step forward for the Cannabis industry.
One reason this matters so much is because of taxes. Legal Cannabis businesses and Dispensary operators have faced heavy financial pressure due to IRS Code 280E. Because Marijuana remained federally classified as a Schedule I substance, many Cannabis companies were unable to claim normal business tax deductions. That meant Dispensary owners often paid far higher taxes than businesses in other industries.
With some Cannabis products now moving into Schedule III classification, many Marijuana businesses could eventually see tax relief. Industry experts believe this could help Cannabis companies invest more into employees, product quality, facility upgrades, and customer experience inside the Dispensary environment.
Another major impact of federal Cannabis rescheduling involves medical research. For decades, strict federal restrictions made Marijuana research difficult for scientists and medical institutions. Researchers faced complicated approval processes and limited access to Cannabis for studies. The new federal changes may allow researchers to study Marijuana more easily for medical conditions such as chronic pain, appetite loss, chemotherapy side effects, and sleep disorders.
Even with these changes, recreational Marijuana is still federally illegal. Adult-use Cannabis sales still depend entirely on individual state laws. Every Dispensary must continue following strict state regulations involving testing, packaging, labeling, and sales compliance. Cannabis products also still cannot legally move freely across state lines in most situations.
At the same time, another major Cannabis issue is gaining attention nationwide: hemp-derived THC products. Since the 2018 Farm Bill legalized hemp with less than 0.3% delta-9 THC, companies have created a huge market for hemp-derived cannabinoids including delta-8 THC and THCA products. Many of these products are sold outside licensed Cannabis Dispensary systems in smoke shops, convenience stores, and online retailers.
This has created major debates within the Marijuana industry. Many licensed Cannabis operators believe intoxicating hemp products should follow the same testing and safety standards required inside a legal Dispensary. Some states are already moving toward tighter regulations on hemp-derived THC products as federal lawmakers continue reviewing national Cannabis policy.
Cannabis investors and stock markets have also reacted strongly to the federal Marijuana changes. After the rescheduling announcement, many Cannabis company stocks increased as investors predicted improved profits and future industry growth. However, uncertainty still remains because broader federal Marijuana legalization has not yet happened.
For everyday consumers, the Dispensary experience may not immediately look different, but long-term changes could still be coming. Federal Cannabis reform could eventually affect pricing, product availability, research, banking access, and how Marijuana businesses operate across the country.
The legal Cannabis market in the United States continues growing rapidly, and 2026 is shaping up to be one of the most important years yet for Marijuana policy. Between federal rescheduling efforts, changing hemp regulations, and expanding state legalization, the Cannabis industry is entering a completely new phase. For every Cannabis consumer, grower, processor, and Dispensary owner, these changes could help shape the future of legal Marijuana in America for years to come.
Sources
Mako Farm Cannabis: Living Soil Grown Flower in Washington Dispensaries
Mako Farm is part of Washington State’s evolving cannabis landscape, offering a consistent presence on dispensary menus while staying rooted in a focused, quality-driven cultivation approach. Based in Burlington, Washington, Mako Farm operates within the state’s regulated I-502 system as a licensed producer and processor, contributing to a market known for its strict compliance standards and wide range of cannabis options.
For customers browsing a dispensary menu, Mako Farm is a familiar name associated with reliable flower selections and modern strain profiles. Their products appear across multiple Washington dispensaries, including High End Cannabis on Broadway in downtown Vancouver, WA, reflecting steady distribution and strong relationships within the local cannabis network. This kind of presence is often a good indicator of a brand that consistently meets retailer expectations for quality, availability, and consumer demand.
Mako Farm focuses primarily on cannabis flower, which remains the backbone of most dispensary menus in Washington. Strain offerings like Motor Breath and Blue Andeze highlight a direction toward terpene-rich, flavor-forward genetics that resonate with today’s consumers. These profiles often combine dessert-like sweetness with balanced effects, making them appealing to a broad range of shoppers, from casual users to more experienced cannabis enthusiasts.
Operating within Washington’s cannabis system means that every Mako Farm product sold in a dispensary has undergone state-mandated testing for potency, pesticides, heavy metals, and microbial contaminants. This ensures a consistent level of safety and transparency across all licensed cannabis products, regardless of brand. For consumers, this means confidence in what they are purchasing, whether they are trying Mako Farm for the first time or returning to a favorite strain.
One of the defining traits of producers like Mako Farm is their ability to stay focused on cultivation practices that prioritize consistency and strain integrity. Rather than stretching production too thin, the approach leans into maintaining stable harvest cycles and preserving the characteristics that make each strain unique. This often translates to flower that delivers dependable aroma, flavor, and overall experience—key factors that influence repeat purchases at the dispensary level.
Mako Farm’s positioning in the Washington cannabis market reflects a balance between accessibility and quality. Their products are widely available enough to be easily found at a dispensary, yet still retain a sense of intentional cultivation that appeals to consumers looking for more than just mass-produced cannabis. This middle ground is an important part of the market, offering dependable options without sacrificing the nuances that define good flower.
In addition to their retail presence, Mako Farm maintains a connection to the broader cannabis community through social channels and brand visibility. This helps give consumers a glimpse into the cultivation side of the business, which has become an increasingly important factor in how cannabis brands build trust and recognition. Transparency, even in small ways, plays a role in how customers choose between the many options available in a dispensary.
Washington’s cannabis market continues to mature, with consumers becoming more informed and selective about what they buy. Brands like Mako Farm contribute to that evolution by offering consistent, well-executed products that fit comfortably into a wide range of consumer preferences. Whether someone is exploring new strains or sticking with proven favorites, having dependable options on the shelf is a key part of the dispensary experience.
As the industry grows, the importance of brands that deliver steady quality cannot be overstated. Mako Farm represents that reliability within Washington’s cannabis space, helping round out the selection available at dispensaries across the region. For shoppers looking for cannabis that balances flavor, consistency, and accessibility, it remains a brand worth keeping an eye on.
https://www.topshelfdata.com/wa/burlington/mako-farm
https://www.fweedom.com/mountlake-menuordering/?dtche%5Bpath%5D=brands%2Fmako-farm
https://northwindcannabis.com/menu/products/2403790/mako-farms-mint-chocolate-chip/
https://www.instagram.com/mako_farm/
YOUR PREFERRED MARIJUANA DISPENSARY
At HEMP we proudly serve both recreational and medical customers. In 2016, High End Market Place was the first cannabis dispensary to be licensed under the new WA State Department of Health medical marijuana program. Since then, we have registered thousands of patients, and have given them access to the highest quality, most ethically sourced cannabis products in the market. Our store is truly Vancouver’s one stop for the best Cannabis Dispensary.